Feedback / Questions
CLSP-1025 - Clasp Therapeutics
https://www.businesswire.com/news/home/20241004195320/en/Clasp-Therapeutics-to-Present-Preclinical-Data-Evaluating-Novel-T-Cell-Engager-Targeting-p53-Mutant-Solid-Tumors
Oct 4, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next